Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.89 |
| ▸ | PRKCG | P05129 | 5/20 | 0.89 |
| ▸ | PRKCB | P05771 | 5/20 | 0.89 |
| ▸ | PRKCH | P24723 | 5/20 | 0.89 |
| ▸ | PRKCE | Q02156 | 5/20 | 0.89 |
| ▸ | PRKCQ | Q04759 | 5/20 | 0.89 |
| ▸ | PRKCD | Q05655 | 5/20 | 0.89 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.89 |
| ▸ | PRKCI | P41743 | 4/20 | 0.89 |
| ▸ | PRKCZ | Q05513 | 4/20 | 0.89 |
| ▸ | PRKD1 | Q15139 | 4/20 | 0.89 |
| ▸ | USP2 | O75604 | 2/20 | 0.89 |
| ▸ | TP53 | P04637 | 2/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.89 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.89 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.89 |
| ▸ | TSHR | P16473 | 1/20 | 0.89 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9306 | 1.00 | PRKCA (0.89) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL3692272 | 1.00 | PRKCA (0.89) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL6844180 | 1.00 | PRKCA (0.89) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL3211990 | 0.95 | PRKCA (0.94) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL1568997 | 0.95 | PRKCA (0.94) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL295345 | 0.95 | PRKCA (0.94) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| Phorbol SCHEMBL3094837 | 0.95 | PRKCA (0.81) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL18399995 | 0.95 | PRKCA (0.95) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL2411275 | 0.95 | PRKCA (0.95) | PRKCAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL31109155 | 0.95 | PRKCA (0.95) | PRKCAPRKCGPRKCBPRKCHPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210139909-A1 | SDF-1 Binding Nucleic Acids | NOXXON PHARMA AG (DE) | 2021-05-13 | — | — | US | disclosed |
| EP-2190991-B1 | SDF-1 BINDING NUCLEIC ACIDS AND THE USE THEREOF | NOXXON PHARMA AG (DE) | 2019-11-06 | — | — | EP | disclosed |
| US-20180163207-A1 | SDF-1 Binding Nucleic Acids | NOXXON PHARMA AG (DE) | 2018-06-14 | — | — | US | disclosed |
| US-9988636-B2 | SDF-1 binding nucleic acids and the use thereof | NOXXON PHARMA AG (DE) | 2018-06-05 | — | — | US | disclosed |
| EP-2041282-B1 | SDF-I BINDING NUCLEIC ACIDS | NOXXON PHARMA AG (DE) | 2018-01-03 | — | — | EP | disclosed |
| US-9822369-B2 | SDF-1 binding nucleic acids | NOXXON PHARMA AG (DE) | 2017-11-21 | — | — | US | disclosed |
| US-20160326531-A1 | SDF-1 Binding Nucleic Acids and the Use Thereof | NOXXON PHARMA AG (DE) | 2016-11-10 | — | — | US | disclosed |
| US-20150232853-A1 | SDF-1 Binding Nucleic Acids | TME Pharma AG (DE) | 2015-08-20 | — | — | US | disclosed |
| US-9035038-B2 | SDF-1 binding nucleic acids | NOXXON PHARMA AG (DE) | 2015-05-19 | — | — | US | disclosed |
| US-20140370034-A1 | SDF-1 Binding Nucleic Acids and the Use Thereof | NOXXON PHARMA AG (DE) | 2014-12-18 | — | — | US | disclosed |
| US-8772257-B2 | SDF-1 binding nucleic acids and the use thereof | NOXXON PHARMA AG (DE) | 2014-07-08 | — | — | US | disclosed |
| US-20130041019-A1 | SDF-1 Binding Nucleic Acids | NOXXON PHARMA AG (DE) | 2013-02-14 | — | — | US | disclosed |
| US-8314223-B2 | SDF-1 binding nucleic acids | NOXXON PHARMA AG (DE) | 2012-11-20 | — | — | US | disclosed |
| US-20110223127-A1 | SDF-1 Binding Nucleic Acids And The Use Thereof | NOXXON PHARMA AG (DE) | 2011-09-15 | — | — | US | disclosed |
| US-20110112172-A1 | SDF-1 Binding Nucleic Acids | NOXXON PHARMA AG (DE) | 2011-05-12 | — | — | US | disclosed |
| EP-2190991-A2 | SDF-1 BINDING NUCLEIC ACIDS AND THE USE THEREOF | Noxxon Pharma AG (DE) | 2010-06-02 | — | — | EP | disclosed |
| EP-2041282-A2 | SDF-I BINDING NUCLEIC ACIDS | Noxxon Pharma AG (DE) | 2009-04-01 | — | — | EP | disclosed |
| WO-2009019007-A2 | SDF-1 BINDING NUCLEIC ACIDS AND THE USE THEREOF | NOXXON PHARMA AG (DE) | 2009-02-12 | — | — | WO | disclosed |
| WO-2008009437-A2 | SDF-I BINDING NUCLEIC ACIDS | NOXXON PHARMA AG (DE) | 2008-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041019-A1 | SDF-1 Binding Nucleic Acids | CXCL12, CCL2, SDF4 | PRKCA 2046/4885PRKCG 2133/4885PRKCB 2478/4885 |
| US-20110112172-A1 | SDF-1 Binding Nucleic Acids | CXCL12, SDF4, CCL2 | PRKCA 1516/4885PRKCG 1517/4885PRKCB 1203/4885 |
| US-20160326531-A1 | SDF-1 Binding Nucleic Acids and the Use Thereof | CXCL12, SDF4, CXCR4 | PRKCA 1735/4885PRKCG 1756/4885PRKCB 2084/4885 |
| US-20110223127-A1 | SDF-1 Binding Nucleic Acids And The Use Thereof | CXCL12, SDF4, CXCR4 | PRKCA 1735/4885PRKCG 1756/4885PRKCB 2084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.